Repression of SMAD7 has not previously been reported after HDL treatment, but this protein is a well-established inhibitor of the TGFβ signalling pathway which regulates fibrosis, inflammation and wound healing and cancer, and loss of Smad7 in mice is associated with enhanced cell proliferation and reduced apoptosis [66]. Here, SMAD7 is linked to cancer.